3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Breast Neoplasms
16
Neoplasms
15
Prostatic Neoplasms
10
Hematologic Neoplasms
9
Colorectal Neoplasms
8
Lung Neoplasms
6
Hematopoietic and Lymphatic System Neoplasm
5
Squamous Cell Carcinoma of Head and Neck
4
Head and Neck Neoplasms
4
Anatomic Stage I Breast Cancer AJCC v8
4
Urinary Bladder Neoplasms
3
Triple Negative Breast Neoplasms
3
Pancreatic Neoplasms
3
Neoplasm Metastasis
3
Mouth Neoplasms
3
Melanoma
3
Malignant Solid Neoplasm
3
Leukemia, Myeloid, Acute
3
Carcinoma, Non-Small-Cell Lung
3
Sarcoma
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Parotid Neoplasms
2
Ovarian Neoplasms
2
Oropharyngeal Neoplasms
2
Head and Neck Carcinoma
2
Glioma
2
Carcinoma, Squamous Cell
2
Carcinoma, Renal Cell
2
Carcinoma, Basal Cell
2
COVID-19
2
Interventions
gallium Ga 68 dotatate
1
Temozolomide
1
Standard of Care
1
Radiotherapy
1
Nivolumab
1
Eflornithine
1
Drug Therapy
1
CLR1404
1
Blood Specimen Collection
1
Automobiles
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Neuroectodermal Tumors, Primitive
×
Standard of Care
×
90 days
×
Clear all
NCT06861244
2026-04-23
PNOC031
University of California, San Francisco
Phase 2
Recruiting
70 enrolled